Deutsche Bank’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-600
| Closed | -$3.46K | – | 3684 |
|
2023
Q3 | $3.46K | Sell |
600
-2,420
| -80% | -$14K | ﹤0.01% | 3560 |
|
2023
Q2 | $21.7K | Sell |
3,020
-988
| -25% | -$7.11K | ﹤0.01% | 3545 |
|
2023
Q1 | $29.5K | Hold |
4,008
| – | – | ﹤0.01% | 3625 |
|
2022
Q4 | $26.8K | Hold |
4,008
| – | – | ﹤0.01% | 3686 |
|
2022
Q3 | $41K | Hold |
4,008
| – | – | ﹤0.01% | 3604 |
|
2022
Q2 | $49K | Buy |
4,008
+3,485
| +666% | +$42.6K | ﹤0.01% | 3721 |
|
2022
Q1 | $11K | Sell |
523
-62
| -11% | -$1.3K | ﹤0.01% | 3952 |
|
2021
Q4 | $35K | Sell |
585
-415
| -42% | -$24.8K | ﹤0.01% | 3912 |
|
2021
Q3 | $94K | Buy |
1,000
+462
| +86% | +$43.4K | ﹤0.01% | 3850 |
|
2021
Q2 | $89K | Sell |
538
-18
| -3% | -$2.98K | ﹤0.01% | 4080 |
|
2021
Q1 | $107K | Buy |
+556
| New | +$107K | ﹤0.01% | 3888 |
|